Form 4: United States Antimony Corp: Director Evans Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Gary C. Evans, Chairman & Co-CEO of United States Antimony Corp, was granted stock options and restricted stock units on March 1, 2024.

Summary

  • Gary C. Evans, Chairman & Co-CEO of United States Antimony Corp, filed a Form 4 on May 22, 2024, reporting transactions related to the company's stock.
  • On March 1, 2024, Evans was granted 250,000 shares of common stock and stock options for 750,000 shares.
  • The 250,000 shares of common stock were granted as part of a restricted stock unit (RSU) award under the Issuer's 2023 Equity Incentive Plan.
  • One-third of the RSU award vested on March 1, 2024, with the remaining two-thirds vesting in equal installments on the annual anniversaries thereafter, contingent upon continued service.
  • The stock options, also granted under the 2023 Equity Incentive Plan, have an exercise price of $0.22.
  • These options will vest in three equal installments starting March 1, 2025, again subject to continued service.
  • Following these transactions, Evans beneficially owns 1,326,050 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of equity can be seen as a positive sign of aligning management with shareholder interests, but also carries potential dilution risks.

Positives

  • The equity grants align management's interests with those of shareholders.
  • The vesting schedule incentivizes continued service and commitment from the Chairman & Co-CEO.

Risks

  • The vesting of the awards is contingent on continued service, creating a potential risk if the executive leaves the company.
  • The exercise of stock options could dilute existing shareholders.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the equity grants.

Industry Context

Equity grants are a common practice in the corporate world to incentivize and retain key executives. The specific terms of the grant, such as the vesting schedule and exercise price, are tailored to the company's specific circumstances and goals.

Comparison to Industry Standards

  • Equity grants are a standard component of executive compensation packages across various industries.
  • Vesting schedules tied to continued service are also common to ensure long-term commitment.
  • The specific amount of equity granted and the exercise price of options are typically benchmarked against peer companies and industry standards to ensure competitiveness.

Stakeholder Impact

  • Shareholders may experience dilution if stock options are exercised.
  • Employees may view the equity grants as a positive sign of the company's commitment to its leadership.
  • The grants incentivize the executive to work towards the long-term success of the company, benefiting all stakeholders.

Next Steps

  • Continued monitoring of the executive's service to ensure vesting conditions are met.
  • Potential exercise of stock options in the future, which could impact the company's capital structure.

Key Dates

DateDescription
03/01/2024Date of the earliest transaction: Grant of stock options and restricted stock units.
03/01/2024One-third of the RSU award vested.
03/01/2025First vesting date for one-third of the stock options.
05/22/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.